Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Add To Watchlist

Bullboard (TSX:CSCI)

View:

Comment by prophetoffactzon Sep 07, 2024 10:28pm

RE:There's a recent SCHEDULE 13D filing of interest

The fund owning shares... Peter Puccetti is a prominent figure in the Canadian investment management industry, primarily known for his role at Goodwood Inc. Here's what we know ...more

Discussion

Post by prophetoffactzon Sep 07, 2024 10:22pm

There's a recent SCHEDULE 13D filing of interest

EOM

137

Discussion

Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents

posted Dec 03, 2024 9:00am by Revive Therapeutics Ltd

Evaluating Bucillamine as a potential treatment for nerve agent exposure, in partnership with Defence R&D Canada – Suffield Research Centre (“DRDC”), an agency of the Canadian Department of National Defence. The DRDC is investigating pharmacological compounds, including Bucillamine, that can mitigate nerve agent induced brain injury. ...read more

Comment by prophetoffactzon Sep 06, 2024 9:29am

RE:CSCI's Biomaterials article published

It's a pre-proof and not the final publication: Biomaterials: What are journal pre-proofs? Journal pre-proofs are Articles in Press that have been peer reviewed and accepted for publication ...more

Discussion

Post by prophetoffactzon Sep 06, 2024 6:55am

CSCI's Biomaterials article published

Modulating Pro-Fibrotic Macrophages Using Yeast Beta-Glucan Microparticles Prepared by Pressurized Gas eXpanded Liquid (PGX) Technology® - ScienceDirect

138

Discussion

Post by prophetoffactzon Sep 02, 2024 8:56am

Yeast beta glucan + methotrexate

Periodontal bone regeneration... "affected 743 million people in the world as the sixth-most prevalent condition" "Animal experiments further demonstrate that cBPM effectively promoted ...more

544

Post by prophetoffactzon Aug 31, 2024 11:32pm

Juvente PGX oat beta glucan, yeast beta glucan blend/AVE

Int J Biol Macromol . ...more

558

Post by prophetoffactzon Aug 31, 2024 10:37pm

Juvente PGX-OBG/Avenanthramide: Wound healing & ageing skin

Based on the research findings, a cream containing PGX oat beta glucan impregnated with avenanthramide could potentially be very effective for wound healing and skin health: Wound ...more

568

Post by prophetoffactzon Aug 31, 2024 9:23pm

Urgent requirement for healthy aging strategies.

Juvente for aging skin: "with aging wound healing is impaired, which exacerbates the risk of infection " Introduction In 2015, the World Health Organization World Report on ...more

537

Comment by prophetoffactzon Aug 31, 2024 12:41pm

RE:Cosciens Biopharm Partners Complete Oat Care Program:

Drugs are late-stage disease interventions. Changing lifestyles and neutraceuticals are the emerging sweet spot for preventing disease. There has been a recent high profile call in the US to 'Make ...more

Discussion

Post by prophetoffactzon Aug 31, 2024 12:24pm

Cosciens Biopharm Partners Complete Oat Care Program:

Consciens Biopharma partners with Dr. Li for its Complete Oat Care program as the sweet spot of early intervention gains traction? Perplexity Ai: The recent discussion around extending the risk ...more

523

Discussion

Post by prophetoffactzon Aug 31, 2024 12:19pm

The sweet spot for neutraceutical option

This article today supports the call to extend the risk period for cardiovascular disease beyond 10 years. This is the sweet spot for neutraceutical options. Early intervention concerning ...more

477

Comment by prophetoffactzon Aug 31, 2024 12:11pm

RE:New England Journal Of Medicine: Inflammation

Addressing inflammation, LDL and Lipoprotein-a beyond current 10 year disease management strategies are recognized in the article. This could be the sweet spot for neutraceutical options. For ...more

Discussion

Post by prophetoffactzon Aug 31, 2024 11:58am

New England Journal Of Medicine: Inflammation

Today's New England Journal of Medicine. This article supports call to extend the risk period for cardiovascular disease beyond 10 years. Importance of inflammation also supported. ...more

526

Discussion

Comment by Hopeforthebeston Aug 31, 2024 11:41am

RE:RE:RE:RE:Market Cap

Well proph just speaking from experience as every valued executive I have known was always reatined for a period of time to assist with transition and sometimes in other capacities. In addition ...more

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Bullboard (TSX:CSCI)

RE:There's a recent SCHEDULE 13D filing of interest

There's a recent SCHEDULE 13D filing of interest

Redefining Neuroprotection: Revive’s Approach to Treating Brain Injury from Nerve Agents

RE:CSCI's Biomaterials article published

CSCI's Biomaterials article published

Yeast beta glucan + methotrexate

Juvente PGX oat beta glucan, yeast beta glucan blend/AVE

Juvente PGX-OBG/Avenanthramide: Wound healing & ageing skin

Urgent requirement for healthy aging strategies.

RE:Cosciens Biopharm Partners Complete Oat Care Program:

Cosciens Biopharm Partners Complete Oat Care Program:

The sweet spot for neutraceutical option

RE:New England Journal Of Medicine: Inflammation

New England Journal Of Medicine: Inflammation

RE:RE:RE:RE:Market Cap

Featured News Links

ReGen III Appoints New CEO and President to Accelerate Commercial and Strategic Opportunities

Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments

Debt-Free Cannabis Company Set for Next Stage of Growth

Learn How this Company is Disrupting Point-of-Care Testing

Unique Battery Metals opportunity in Quebec

Discover Options Trading Strategies to Minimize your Tax Burden

Rig Count Soars as Utilization Surpasses Industry Averages

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSX:CSCI)

Featured News Links